Osteonecrosis in Systemic Lupus Erythematosus: An Early, Frequent, and Not Always Symptomatic ComplicationReportar como inadecuado




Osteonecrosis in Systemic Lupus Erythematosus: An Early, Frequent, and Not Always Symptomatic Complication - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Autoimmune DiseasesVolume 2012 2012, Article ID 725249, 7 pages

Review ArticleRheumatology Unit, Department of Medicine, University of Verona, 37134 Verona, Italy

Received 16 May 2012; Accepted 16 June 2012

Academic Editor: Hiroshi Okamoto

Copyright © 2012 Paola Caramaschi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Osteonecrosis may complicate the course of systemic lupus erythematosus and may contemporaneously affect multiple joints. The major risk factor associated with the development of osteonecrosis is the use of glucocorticoid at high doses. Recent studies using serial MRI, which represents the “gold standard” for the early detection of osteonecrosis, yielded some interesting findings about the natural history of this clinical entity. Osteonecrosis in the majority of the cases is asymptomatic and occurs early in the course of the disease. Its later occurrence is associated with lupus flare that requires the increase of corticosteroid dose. The optimal treatment of osteonecrosis is controversial. In case of silent osteonecrosis involving a small area conservative strategy is usually adequate. When lesions are symptomatic surgical treatment as core decompression or free vascularized fibular grafting is required; extracorporeal shockwave treatment may represent an alternative therapeutic approach. When the lesion has a medium-large dimension or involves a weight-bearing area bone collapse is a common complication requiring total joint replacement. Coadministration of bisphosphonate or warfarin with high doses of corticosteroid might be a promising preventive strategy of osteonecrosis.





Autor: Paola Caramaschi, Domenico Biasi, Ilaria Dal Forno, and Silvano Adami

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados